LPA receptor signaling: pharmacology, physiology, and pathophysiology

YC Yung, NC Stoddard, J Chun - Journal of lipid research, 2014 - ASBMB
Lysophosphatidic acid (LPA) is a small ubiquitous lipid found in vertebrate and
nonvertebrate organisms that mediates diverse biological actions and demonstrates …

Lipid map of the mammalian cell

G van Meer, AIPM de Kroon - Journal of cell science, 2011 - journals.biologists.com
Technological developments, especially in mass spectrometry and bioinformatics, have
revealed that living cells contain thousands rather than dozens of different lipids [for …

GPCRs: Emerging anti-cancer drug targets

AN Gutierrez, PH McDonald - Cellular signalling, 2018 - Elsevier
G protein-coupled receptors (GPCRs) constitute the largest and most diverse protein family
in the human genome with over 800 members identified to date. They play critical roles in …

G protein-coupled receptors in cancer

R Bar-Shavit, M Maoz, A Kancharla, JK Nag… - International journal of …, 2016 - mdpi.com
Despite the fact that G protein-coupled receptors (GPCRs) are the largest signal-conveying
receptor family and mediate many physiological processes, their role in tumor biology is …

Structure of the active Gi-coupled human lysophosphatidic acid receptor 1 complexed with a potent agonist

H Akasaka, T Tanaka, FK Sano, Y Matsuzaki… - Nature …, 2022 - nature.com
Abstract Lysophosphatidic acid receptor 1 (LPA1) is one of the six G protein-coupled
receptors activated by the bioactive lipid, lysophosphatidic acid (LPA). LPA1 is a drug target …

Acyltransferases and transacylases that determine the fatty acid composition of glycerolipids and the metabolism of bioactive lipid mediators in mammalian cells and …

A Yamashita, Y Hayashi, Y Nemoto-Sasaki, M Ito… - Progress in lipid …, 2014 - Elsevier
Over one hundred different phospholipid molecular species are known to be present in
mammalian cells and tissues. Fatty acid remodeling systems for phospholipids including …

Management strategies for liver fibrosis

A Altamirano-Barrera, B Barranco-Fragoso… - Annals of …, 2017 - medigraphic.com
Liver fibrosis resulting from chronic liver injury are major causes of morbidity and mortality
worldwide. Among causes of hepatic fibrosis, viral infection is most common (hepatitis B and …

Melanoma cells break down LPA to establish local gradients that drive chemotactic dispersal

AJ Muinonen-Martin, O Susanto, Q Zhang… - PLoS …, 2014 - journals.plos.org
The high mortality of melanoma is caused by rapid spread of cancer cells, which occurs
unusually early in tumour evolution. Unlike most solid tumours, thickness rather than …

Lysophosphatidic acid receptor 1 antagonist SAR100842 for patients with diffuse cutaneous systemic sclerosis: a double‐blind, randomized, eight‐week placebo …

Y Allanore, O Distler, A Jagerschmidt… - Arthritis & …, 2018 - Wiley Online Library
Objective Preclinical studies suggest a role for lysophosphatidic acid (LPA) in the
pathogenesis of systemic sclerosis (SS c). We undertook this study to assess SAR 100842, a …

Lysophosphatidic acid‐induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1/TRPV1

H Kittaka, K Uchida, N Fukuta… - The Journal of …, 2017 - Wiley Online Library
Key points Lysophosphatidic acid (LPA) is an itch mediator, but not a pain mediator by a
cheek injection model. Dorsal root ganglion neurons directly respond to LPA depending on …